Paul A. Laviolette - Jan 9, 2025 Form 4 Insider Report for PULSE BIOSCIENCES, INC. (PLSE)

Role
Chief Executive Officer, Director
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Stock symbol
PLSE
Transactions as of
Jan 9, 2025
Transactions value $
$0
Form type
4
Date filed
1/13/2025, 07:45 PM
Previous filing
Aug 13, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLSE Stock Option (right to buy) Award $0 +450K $0.00 450K Jan 9, 2025 Common Stock 450K $18.43 Direct F1
transaction PLSE Stock Option (right to buy) Award $0 +1.05M $0.00 1.05M Jan 9, 2025 Common Stock 1.05M $18.43 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares subject to the option will vest on the three-year anniversary of the grant and the remaining shares will vest on the four-year anniversary of the grant, subject to the Reporting Person's continued service through each vesting date.
F2 The shares subject to this option are subject to five tranches of performance-based vesting criteria tied to certain operating targets and the Issuer's market capitalization ranging from $3 billion to $9 billion, in all cases, subject to the Reporting Person's continued service through each vesting milestone.